Badger Meter Inc
BMI NYSE Totalizing Fluid Meters & Counting Devices Financials FY2016βFY2025
What Badger Meter Inc does
No business description yet.
- Legal name
- BADGER METER INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 17, 2026
- Accession Β· CIK
- 0001193125-26-054739
0000009092
Revenue and margins
Badger Meter Inc had $917M of revenue in fiscal 2025, up 10.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 17.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $170M in fiscal 2025, 18.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Badger Meter Inc returned $58.5M to shareholders in fiscal 2025, 34% of free cash flow. The diluted share count rose 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Badger Meter Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $87.2M | $138M | $192M | $295M | $226M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β1.0x | β1.4x | β1.5x | β1.7x | β1.2x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 3.2x | 3.2x | 3.4x | 4.6x | 3.4x |
| Quick ratio | 2.0x | 2.1x | 2.2x | 3.4x | 2.4x |
| Total assets | $531M | $603M | $717M | $816M | $974M |
| Total liabilities | $128M | $161M | $200M | $210M | $260M |
| Shareholders' equity | $403M | $442M | $516M | $606M | $713M |
| Net debt (β = net cash) | β$87.2M | β$138M | β$192M | β$295M | β$226M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 6 / 9 | 8 / 9 | 6 / 9 | 6 / 9 | 3 / 9 | 7 / 9 | 7 / 9 | 4 / 9 |
| Accruals ratio | β6.8% | β4.1% | β8.3% | β8.2% | β9.0% | β5.3% | β2.8% | β2.7% | β3.9% | β4.7% |
| Altman Z'' | 7.39 | 6.65 | 8.43 | 9.25 | 8.72 | 8.70 | 8.58 | 8.74 | 9.91 | 8.71 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $394M | $402M | $434M | $425M | $426M | $505M | $566M | $704M | $827M | $917M |
| Net interest income | β$0.9M | β$0.8M | β$1.2M | β$0.3M | β$0.0M | $0.0M | $0.6M | $4.0M | $8.6M | $5.1M |
| Gross profit | $151M | $156M | $162M | $164M | $168M | $205M | $220M | $276M | $329M | $382M |
| Research and development | $10.6M | $10.6M | $11.1M | $11.9M | $11.6M | $14.7M | $15.8M | $19.0M | $19.2M | $21.6M |
| Operating income | $52.7M | $56.6M | $56.9M | $62.1M | $65.2M | $78.7M | $87.3M | $118M | $158M | $183M |
| Pretax income | $49.8M | $54.8M | $35.9M | $61.6M | $65.0M | $78.6M | $87.7M | $122M | $167M | $189M |
| Income tax | $17.5M | $20.3M | $8.1M | $14.4M | $15.6M | $17.7M | $21.2M | $29.4M | $41.6M | $47.0M |
| Net income | $32.3M | $34.6M | $27.8M | $47.2M | $49.3M | $60.9M | $66.5M | $92.6M | $125M | $142M |
| Diluted EPS | $1.11 | $1.19 | $0.95 | $1.61 | $1.69 | $2.08 | $2.26 | $3.14 | $4.23 | $4.79 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $56.2M | $49.8M | $60.4M | $80.7M | $89.6M | $87.5M | $82.5M | $110M | $155M | $184M |
| Capital expenditure | $10.6M | $15.1M | $8.6M | $7.5M | $9.1M | $6.7M | $5.9M | $12.0M | $12.8M | $14.0M |
| Free cash flow | $45.6M | $34.7M | $51.7M | $73.2M | $80.5M | $80.8M | $76.6M | $98.1M | $142M | $170M |
| Depreciation and amortization | $10.7M | $12.1M | $11.4M | $11.6M | $12.3M | $11.3M | $11.1M | $10.9M | $11.1M | $11.1M |
| Stock-based compensation | $1.5M | $1.7M | $4.2M | $1.2M | $1.4M | $2.3M | $3.1M | $5.2M | $6.2M | $9.2M |
| Acquisitions | $1.8M | $20.4M | $8.0M | β | $29.1M | $45.3M | $0.0M | $17.1M | $3.0M | $184M |
| Share buybacks | $0.0M | $4.4M | $4.8M | $5.2M | $3.1M | $0.5M | $0.4M | $0.0M | $0.0M | $15.0M |
| Dividends paid | $12.5M | $14.2M | $16.3M | $18.6M | $20.3M | $22.2M | $24.9M | $29.1M | $35.8M | $43.5M |
| Dividends and buybacks | $12.5M | $18.6M | $21.1M | $23.8M | $23.5M | $22.6M | $25.3M | $29.1M | $35.8M | $58.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $7.3M | $11.2M | $13.1M | $48.9M | $72.3M | $87.2M | $138M | $192M | $295M | $226M |
| Total debt | $38.0M | $44.6M | $18.1M | $4.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $151M | $159M | $165M | $200M | $224M | $261M | $348M | $442M | $540M | $507M |
| Current liabilities | $75.8M | $93.1M | $60.0M | $57.2M | $68.0M | $82.1M | $110M | $132M | $118M | $151M |
| Inventory | $77.7M | $85.2M | $80.8M | $81.9M | $81.6M | $99.6M | $120M | $154M | $143M | $152M |
| Property and equipment, net | $90.2M | $93.6M | $90.3M | $85.8M | $82.7M | $78.1M | $73.5M | $73.9M | $74.3M | $79.6M |
| Goodwill | $49.3M | $67.4M | $71.3M | $71.3M | $88.7M | $104M | $101M | $113M | $112M | $236M |
| Intangible assets | $51.9M | $59.3M | $55.4M | $48.2M | $53.6M | $64.2M | $53.6M | $53.7M | $45.1M | $118M |
| Total assets | $350M | $392M | $393M | $422M | $471M | $531M | $603M | $717M | $816M | $974M |
| Total liabilities | $93.5M | $114M | $89.2M | $90.8M | $110M | $128M | $161M | $200M | $210M | $260M |
| Shareholders' equity | $256M | $277M | $304M | $331M | $361M | $403M | $442M | $516M | $606M | $713M |
| Margins | ||||||||||
| Gross margin | 38.2% | 38.7% | 37.4% | 38.5% | 39.5% | 40.7% | 38.9% | 39.3% | 39.8% | 41.7% |
| Operating margin | 13.4% | 14.1% | 13.1% | 14.6% | 15.3% | 15.6% | 15.4% | 16.8% | 19.1% | 20.0% |
| EBITDA margin | 16.1% | 17.1% | 15.7% | 17.4% | 18.2% | 17.8% | 17.4% | 18.3% | 20.5% | 21.2% |
| Net margin | 8.2% | 8.6% | 6.4% | 11.1% | 11.6% | 12.1% | 11.8% | 13.2% | 15.1% | 15.5% |
| FCF margin | 11.6% | 8.6% | 11.9% | 17.2% | 18.9% | 16.0% | 13.5% | 13.9% | 17.2% | 18.5% |
| Net interest share of revenue | β0.2% | β0.2% | β0.3% | β0.1% | β0.0% | 0.0% | 0.1% | 0.6% | 1.0% | 0.6% |
| Returns | ||||||||||
| Return on capital | 11.9% | 11.8% | 14.3% | 16.6% | 17.1% | 19.3% | 21.7% | 27.6% | 38.1% | 28.3% |
| Return on capital employed | 19.2% | 19.0% | 17.1% | 17.0% | 16.2% | 17.5% | 17.7% | 20.2% | 22.6% | 22.3% |
| Return on equity | 12.6% | 13.0% | 9.6% | 14.9% | 14.3% | 15.9% | 15.7% | 19.3% | 22.3% | 21.5% |
| Return on assets | 9.2% | 9.3% | 7.1% | 11.6% | 11.0% | 12.2% | 11.7% | 14.0% | 16.3% | 15.8% |
| Return on tangible equity | 20.8% | 22.9% | 15.7% | 22.3% | 22.5% | 26.0% | 23.1% | 26.5% | 27.8% | 39.4% |
| Growth | ||||||||||
| Revenue growth | β | 2.2% | 7.8% | β2.1% | 0.2% | 18.7% | 11.9% | 24.4% | 17.5% | 10.9% |
| Net income growth | β | 7.0% | β19.6% | 69.8% | 4.6% | 23.4% | 9.2% | 39.3% | 34.9% | 13.4% |
| EPS growth | β | 7.2% | β20.2% | 69.5% | 5.0% | 23.1% | 8.7% | 38.9% | 34.7% | 13.2% |
| FCF growth | β | β23.9% | 49.1% | 41.6% | 10.0% | 0.3% | β5.2% | 28.2% | 44.9% | 19.3% |
| Share count change | β | 0.0% | 0.3% | 0.0% | 0.0% | 0.3% | 0.3% | 100,090.5% | 0.3% | 0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.5x | 0.5x | 0.1x | β0.6x | β0.9x | β1.0x | β1.4x | β1.5x | β1.7x | β1.2x |
| Debt / equity | 0.1x | 0.2x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 2.0x | 1.7x | 2.7x | 3.5x | 3.3x | 3.2x | 3.2x | 3.4x | 4.6x | 3.4x |
| Quick ratio | 1.0x | 0.8x | 1.4x | 2.1x | 2.1x | 2.0x | 2.1x | 2.2x | 3.4x | 2.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.7% | 3.7% | 2.0% | 1.8% | 2.1% | 1.3% | 1.0% | 1.7% | 1.6% | 1.5% |
| Stock comp / revenue | 0.4% | 0.4% | 1.0% | 0.3% | 0.3% | 0.5% | 0.6% | 0.7% | 0.7% | 1.0% |
| Payouts / FCF | 27.3% | 53.7% | 40.7% | 32.5% | 29.1% | 28.0% | 33.1% | 29.6% | 25.2% | 34.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 6.0 | 8.0 | 6.0 | 6.0 | 3.0 | 7.0 | 7.0 | 4.0 |
| Altman Z'' | 7.4 | 6.6 | 8.4 | 9.2 | 8.7 | 8.7 | 8.6 | 8.7 | 9.9 | 8.7 |
| Accruals ratio | β6.8% | β4.1% | β8.3% | β8.2% | β9.0% | β5.3% | β2.8% | β2.7% | β3.9% | β4.7% |
Source: SEC EDGAR XBRL filings (CIK 0000009092). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.